Chris Leo

Chris Leo is an accomplished professional in the biopharmaceutical and medical technology sectors, currently serving as a member of the Accelerator Venture Board at the Chicago Biomedical Consortium since January 2022. As Managing Director at Back Bay Life Science Advisors since 2010, Chris Leo leads initiatives in research and development, market analysis, and corporate growth for a diverse range of clients, including established biopharma and medtech firms as well as innovative early-stage companies. Previous roles include Director of Competitive Strategy at Genzyme, where Chris Leo managed market and competitor analyses, and Director at Leerink Swann Strategic Advisors, focusing on strategic planning and business development. Chris Leo's expertise is rooted in a PhD in Biochemistry from UMass Chan Medical School and a Bachelor's degree in Biology from the College of the Holy Cross.